#Sweden #Stockholm #Nevisense #SciBase #EIS

Introduction

In the field of dermatology, effective assessment of skin barrier integrity is critical in diagnosing and managing various skin disorders. A new study published in Contact Dermatitis highlights the capabilities of Nevisense's Electrical Impedance Spectroscopy (EIS) as a valuable tool for evaluating skin barrier impairment. This research underscores the importance of accurate and sensitive diagnostic methods in caring for skin health.

A Breakthrough Study

The study titled Assessing Skin Barrier Integrity: A Comparative Study Using Transepidermal Water Loss, Electrical Impedance Spectroscopy, and Corneometry demonstrates how EIS compares favorably against traditional assessment techniques. Traditional methods, such as Transepidermal Water Loss (TEWL) and Corneometry, have long been used in dermatology, but they often miss subtle changes in skin structure that EIS can detect. The research confirms that EIS not only identifies these early structural alterations but also offers a more quantifiable method for assessing skin barrier damage.

Key Findings

1. Higher Sensitivity: EIS technology exhibited a superior capability in capturing early and subtle structural changes within the skin that conventional TEWL measurements often overlook. This higher sensitivity renders EIS an indispensable complement to established diagnostic methods.

2. Biomarker Potential: The study also suggests that EIS could serve as an early biomarker for skin barrier impairment, particularly because it is influenced by factors like cell cohesion and lipid composition in the skin. In contrast, TEWL primarily reflects water flux across the epidermis, underscoring a gap in capturing dynamic changes that EIS addresses.

3. Complementary Role of EIS: The findings accentuate the role of EIS as a robust supplemental approach for skin barrier assessments, filling in the gaps left by traditional measures. This capability could significantly advance the monitoring and understanding of skin health, thereby guiding effective interventions in clinical practice.

Industry Impact

Pia Renaudin, CEO of SciBase, reflected on the study's implications, stating, "This study further validates EIS and Nevisense as a powerful tool for assessing skin barrier impairment. By offering a robust complement to traditional methods, Nevisense enables researchers and product developers to directly monitor skin barrier integrity and gain deeper insight into the skin's structural condition." This validation may lead to broader acceptance and utilization of EIS in both clinical and research settings, paving the way for advancements in dermatological diagnostics.

What’s Next for SciBase?

SciBase continues to pave the way in dermatological diagnostics, grounded in over 20 years of research from the Karolinska Institute in Stockholm. With Nevisense integrating AI and EIS, their mission remains clear: to enhance diagnostic accuracy, improve patient outcomes, and reduce overall healthcare costs through proactive skin health management. The company's technology is not only poised to support clinicians in timely interventions but also promises to minimize patient suffering in skin-related health issues.

Conclusion

With the publication of this pivotal study, Nevisense's EIS technology has solidified its position as an essential method for effective skin barrier assessment. As dermatology evolves, innovations like Nevisense are vital for advancing diagnostic practices and ultimately enhancing patient care in skin health. For further information, you can explore the full details of the study in Contact Dermatitis or visit SciBase for more about their pioneering technologies.